Adocia Stock price

Equities

ADOC

FR0011184241

Biotechnology & Medical Research

Market Closed - Euronext Paris 16:35:02 01/03/2024 GMT 5-day change 1st Jan Change
9.44 EUR +3.28% Intraday chart for Adocia -5.32% -18.20%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Days!
Enjoy this offer
* See conditions on site

Financials

Sales 2023 * 18.7M 20.26M 1.6B Sales 2024 * 50M 54.18M 4.29B Capitalization 133M 144M 11.39B
Net income 2023 * 14M 15.17M 1.2B Net income 2024 * 26M 28.18M 2.23B EV / Sales 2023 * 7.28 x
Net Debt 2023 * 3.3M 3.58M 283M Net cash position 2024 * 22.5M 24.38M 1.93B EV / Sales 2024 * 2.21 x
P/E ratio 2023 *
4.6 x
P/E ratio 2024 *
2.54 x
Employees 97
Yield 2023 *
-
Yield 2024 *
-
Free-Float 95.08%
More Fundamentals * Assessed data
Dynamic Chart
1 day+3.28%
1 week-5.32%
Current month+3.28%
1 month-18.76%
3 months+12.38%
6 months-16.61%
Current year-18.20%
More quotes
1 week
8.80
Extreme 8.8
11.20
1 month
8.80
Extreme 8.8
11.20
Current year
8.80
Extreme 8.8
12.40
1 year
2.75
Extreme 2.745
16.16
3 years
2.75
Extreme 2.745
16.16
5 years
2.75
Extreme 2.745
22.60
10 years
2.75
Extreme 2.745
94.24
More quotes
Managers TitleAgeSince
Founder 53 15/12/05
Founder 78 15/12/05
Director of Finance/CFO - 31/12/05
Members of the board TitleAgeSince
Founder 78 15/12/05
Director/Board Member 67 20/05/21
Director/Board Member 58 17/06/13
More insiders
Date Price Change Volume
01/03/24 9.44 +3.28% 119,170
29/02/24 9.14 -6.35% 137,482
28/02/24 9.76 +0.31% 273,351
27/02/24 9.73 -3.85% 98,201
26/02/24 10.12 +2.85% 342,415

Real-time Euronext Paris, March 01, 2024 at 04:35 pm

More quotes
Adocia is a biotechnology company that specializes in the development of innovative formulations of already-approved therapeutic proteins for the treatment of diabetes. At the end of 2022, the group had a portfolio of 4 products in clinical development (BioChaperone Lispro U100 and U200, BioChaperone Combo, M1Pram-ADO09 and BioChaperone Glucagon) and 3 preclinical-stage products (BioChaperone® LisPram, BioChaperone® Glargine GLP-1 and BioChaperone® Glucagon GLP-1).
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
-
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
9.44 EUR
Average target price
9.7 EUR
Spread / Average Target
+2.75%
Consensus
  1. Stock
  2. Equities
  3. Stock Adocia - Euronext Paris
-40% Limited-time offer: Our subscriptions help you unlock the best investment opportunities.
SIGN UP NOW